OBJECTIVE: To examine the prevalence of foot @entity1066 , foot at risk, and the associated risk factors among @entity6 . METHODS: A cross-sectional design was applied on 1000 @entity6 @entity1 (both type-1 and type-2) aged >20 years. The @entity1 were selected systematically from among every second @entity1 visiting the @entity6 clinics at National Center for @entity6 , Endocrinology, and Genetics (NCDEG) in Amman, Jordan. The @entity1 were interviewed, examined, and then their medical records were reviewed. The factors including @entity16 , @entity16 , @entity21115 , @entity5327 , @entity989 , and dermatological changes were recorded for all @entity1 . Foot at risk was identified based on the risk category classification and foot @entity1066 were evaluated based on the Wagner's classification system. RESULTS: A total of 53 (5.3%) @entity1 had foot @entity1066 , 17 (1.7%) had undergone amputations, and 172 (17.2%) had foot at risk. A total of 62 @entity1 were identified in the risk category-1, 82 in the risk category-2, and 28 in the risk category-3. Loss of protective sensation was detected in 174 (17.4%) @entity1 , @entity1109 in 162 (16.2%) @entity1 , absence of posterior tibial pulse in 115 (11.5%) @entity1 , absence of dorsalis pedis pulse in 97 (9.7%) @entity1 , and @entity613 in 72 (7.2%) @entity1 . Loss of protective sensation (p < 0.000), @entity1109 (p < 0.039), and @entity5327 (p = 0.02) were found to be significantly higher in @entity6 @entity1 with foot @entity1066 than in those without foot @entity1066 . CONCLUSIONS: The prevalence of foot ulcer in Jordan was 5.3%, while foot at risk was prevalent in 17.2% @entity1 . @entity1 with @entity1109 , @entity1109 , and @entity5327 of the lower limbs were found to be at a higher risk for the development of foot ulceration.

Prevalence of foot @entity1066 , foot at risk and associated risk factors among XXXX .

@entity1 :: ('9606', 'Species') :: ['participants', 'Patients', 'patients', 'patient'] @entity6 :: ('MESH:D003920', 'Disease') :: ['Diabetes', 'diabetic', 'diabetes', 'Jordanian diabetics'] @entity1066 :: ('MESH:D014456', 'Disease') :: ['ulcers'] @entity16 :: ('MESH:D009422', 'Disease') :: ['sensory neuropathy', 'vibratory neuropathy'] @entity1109 :: ('MESH:D012678', 'Disease') :: ['loss of vibratory sensation', 'loss of protective sensation'] @entity613 :: ('MESH:D007383', 'Disease') :: ['claudication'] @entity21115 :: ('MESH:C564945', 'Disease') :: ['painful neuropathy'] @entity989 :: ('MESH:D012164', 'Disease') :: ['retinopathy'] @entity5327 :: ('MESH:D065666', 'Disease') :: ['vascular insufficiency']
@entity6 :: (MESH:D003920,Disease) :: ['Jordanian diabetics']
